Shanghai - Delayed Quote CNY

Beijing Tongrentang Co., Ltd (600085.SS)

25.07 +0.64 (+2.62%)

At close: October 30 at 3:00:02 PM GMT+8

Chart Range Bar

Loading chart for 600085.SS

Previous Close 24.43
Open 24.44
Bid 25.06 x --
Ask 25.07 x --
Day's Range 24.33 - 25.20
52 Week Range 21.87 - 35.87
Volume 11,721,393
Avg. Volume 6,687,339
Market Cap (intraday) 34.383B
Beta (5Y Monthly) --
PE Ratio (TTM) 35.31
EPS (TTM) 0.71
Earnings Date --
Forward Dividend & Yield 0.50 (1.99%)
Ex-Dividend Date Jul 1, 2026
1y Target Est 32.19

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.

gf.tongrentang.com

17,284

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

600085.SS

20.57%

SSE Composite Index (000001.SS)

9.32%

1-Year Return

600085.SS

24.39%

SSE Composite Index (000001.SS)

9.73%

3-Year Return

600085.SS

49.68%

SSE Composite Index (000001.SS)

19.11%

5-Year Return

600085.SS

15.87%

SSE Composite Index (000001.SS)

1.46%

Earnings Per Share (GAAP)

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q3 FY25

Revenue 3.54B

Earnings --

Profit Margin 0.00%

FY24

FY25

0.0%

Analyst Price Targets

20.50 Low

32.19 Average

25.07 Current

45.54 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

5.85%
Return on Assets (ttm)

2.45%
Return on Equity (ttm)

5.14%
Revenue (ttm)

15.01B
Net Income Avi to Common (ttm)

877.55M
Diluted EPS (ttm)

0.71

Balance Sheet and Cash Flow

Total Cash (mrq)

10.87B
Total Debt/Equity (mrq)

14.73%
Levered Free Cash Flow (ttm)

2.12B

000538.SZ Yunnan Baiyao Group Co.,Ltd

53.71 +1.47%

600196.SS Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

22.66 +1.57%

600018.SS Shanghai International Port (Group) Co., Ltd.

5.80 +5.84%

600009.SS Shanghai International Airport Co., Ltd.

24.12 +1.39%

600016.SS China Minsheng Banking Corp., Ltd.

3.5400 0.00%

U.S. markets closed

Beijing Tongrentang Co., Ltd (600085.SS)

1.75%

5.60%

-9.72%

-22.29%

-26.03%

-21.85%

917.04%

Beijing Tongrentang Co., Ltd Overview Drug Manufacturers - Specialty & Generic / Healthcare

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share (GAAP)

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch